"Finding hope for the future"
"Finding hope for the future"
Reliant Medical Research
THERAPEUTIC EXPERIENCE
Infections/Parasitic Disease: HIV, Meningitis, Pneumonia, Influenza
Dermatology: Fungal Infection, Dermatitis, Acne, Rosacea.
Endocrine/Metabolic: Type 2 Diabetes Mellitus, Dislipidemia, Gout
Circulatory: Acute Coronary Syndrome, Hypertension
Respiratory: Asthma, allergy Rhinitis and COPD, Pulmonary Disease
Musculoskeletal: Rheumatoid Arthritis, Degenerative Osteoarthritis
Nervous Systems: Epilepsy, Diabetic Neuropathy, Pain Management
Mental Disorders: Major Depression, Anxiety, ADHD, Alzheimer Disease
Digestive System: Acid Peptic Disease, IBS, Constipation
Our Experience in Research
Reliant Medical Research is dedicated to improving and advancing medicine
through ground-breaking research and extensive clinical trials. Our physicians have vast experience in research, are highly trained and passionate about working together to find cures. Our physicians also work with many multi-specialty physicians, talented experts in their fields, to ensure we offer the best quality, safety and service to our patients and clinical research studies. Reliant and it's staff are striving to help improve your quality of life.
Reliant Medical Research
MOST RECENT CLINICAL TRIAL PARTICIPATION
- Durable response therapy evaluation of new onset Type I Diabetes.
- Randomized, double-blind, two way, cross-over, bio-equivalence study of XXX and Taxotere in patients with locally advanced or metastatic Non-small Cell Lung Cancer after Platinum therapy failure.
- Phase 2 four-week, multicenter, double blind, placebo-controlled parallel group study to evaluate the efficacy and safety of XXX in subjects with Type II Diabetes with ascending dose safety and pharmacokinetic period.
- Phase 2 randomized, double blind, placebo controlled, multicenter study evaluating efficacy and safety of 2 doses of XXX in older patients with uncomplicated Influenza.
- Phase 3 clinical study for the treatment of Cold Sore.
- Phase 3 multicenter, randomized, double-blind, placebo-controlled study to evaluate cardiovascular outcomes following treatment with hypoglycemic agent, in addition to standard care in subjects with Type II Diabetes.
- Phase 3 randomized, double-blinded to evaluate the safety and efficacy of XXX in subjects with a recent Acute Coronary Syndrome.
- Phase 3 study designed to investigate the safety and efficacy of XXX in subjects with recurrent Herpes Labialis.
- Efficacy and safety of XXX as adjunctive therapy for refractory Partial Epilepsy Disorder in a double blind, randomized, placebo-controlled, parallel-group, multicenter trial.
- A randomized, double blinded, placebo controlled, multicenter trial to assess the efficacy and safety of Oxycodone/XXX, controlled released tablets compared to placebo in opioid experienced subjects with Severe Chronic Pain who require around the clock+ opioid therapy.
- Study of XXX and Acyclovir for the treatment of Herpes Simplex Labialis in immunocompromised patients.
- A randomized, double-blinded, placebo-controlled, multicenter study of Probuphin in patients with Opioid Dependence.
- Double blinded, randomized, comparable-controlled study, to assess the safety, efficacy and pharmacodynamics of 2 doses and 2 durations of XXX injection administered intravenously in patients with complicated Urinary Tract Infections or Acute Pyelonephritis.
. A multicenter, randomized, double-blind, double-dummy, parallel group, active-controlled, forced-titration, 12-week comparison of XXX with XXX and Valsartan versus Enalapril on changes in central aortic stiffness in patients with Heart Failure and Reduced Ejection fraction: EVALUATE-HF.
. Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of XXX for induction and maintenance therapy in subjects with Moderately to Severe Active Ulcerative Colitis.
. Phase 3 multicenter, open-label extension (OLE) study to evaluate the long-term safety of XXX in subjects with Ulcerative Colitis.
. Phase 4 prospective randomized 12-week controlled study of visual field change in subjects with Partial Seizures receiving XXX or placebo.
CURRENT STUDIES
. Tourette Syndrome Study
. A multi-center, randomized, double-blind, double-dummy, parallel group, active-controlled, forced-titration, 12-week comparison of XXX with XXX and Valsartan versus Enalapril on changes in central aortic stiffness in patients with Heart Failure and Reduced Ejection fraction: EVALUATE-HF.
. Multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of XXX for induction and maintenance therapy in subjects with Moderately to Severe Active Ulcerative Colitis.
. Phase 3 multicenter, open-label extension (OLE) study to evaluate the long-term safety of XXX in subjects with Ulcerative Colitis.
. Phase 4 prospective randomized 12-week controlled study of visual field change in subjects with Partial Seizures receiving XXX or placebo.
About Us
Our Health Mission
Reliant Medical Research (RMR) is an independent clinical research company, that provides and promotes the highest quality services in Clinical Trials. Improving and advancing medicine through clinical trials and extensive research. Committed to providing an exceptional research experience to our patients with care and respect. Our mission and vision is in finding hope for the future.
Experience and Professionalism
Reliant Medical Research has delivered exceptional research time and time again. Many clinical trials have been conducted over the past 30 years by the outstanding team at Reliant. Clinical Trials including cancer research, high-blood pressure, and diabetes are just some of the many. Reliant's dedication to improving medical care has given us the reputation for high quality research and a competitive patient recruitment.
President & PI
Founder and principal investigator, Ramses Vega, MD PhD, specializing in Internal and Emergency Medicine, has improved the lives of thousands of patients for almost 30 years. Studied medicine in Puerto Rico and completed his training at Henry Ford Hospital in Detroit, Michigan. His foundation in research started early in his training and through his career as a physician. He participated in research, while working and teaching at Miami VA and University of Miami Hospital. Also, had the privilege to work with George Einstein, in his research work. Dr. Vega is very passionate about research and teaching,
Our Team
Ramses Vega, MD, PhD
Ramses Vega, MD, PhD
Ramses Vega, MD, PhD
Internal Medicine
Principle Investigator
Maida Pereira. MD
Ramses Vega, MD, PhD
Ramses Vega, MD, PhD
General Medicine
Sub-Investigator
Dr. Itzel Vega Crespo, DBA, MSN-Edu, RN-BSN
Dr. Itzel Vega Crespo, DBA, MSN-Edu, RN-BSN
Dr. Itzel Vega Crespo, DBA, MSN-Edu, RN-BSN
CRC and IRB Coordinator
Karen Vega, RT, MA
Dr. Itzel Vega Crespo, DBA, MSN-Edu, RN-BSN
Dr. Itzel Vega Crespo, DBA, MSN-Edu, RN-BSN
Regulatory Manager
Our Team
Maria Rojas
Ubaldo A Miranda, MD
Kirenia Barrios
Medical Assistant and Lab Manager
Kirenia Barrios
Ubaldo A Miranda, MD
Kirenia Barrios
Medical Assistant and Lab Manager
Ubaldo A Miranda, MD
Ubaldo A Miranda, MD
Ubaldo A Miranda, MD
Clinical Research Coordinator